Skip to main content
AVT Natural Products Ltd. logo

AVT Natural Products Ltd. — Investor Relations & Filings

Ticker · AVTNPL ISIN · INE488D01021 LEI · 335800FAQUEXHWLG7I81 BSE.NS Manufacturing
Open in API
Filings indexed 804 across all filing types
Latest filing 2026-04-27 Regulatory Filings
Country IN India
Listing BSE.NS AVTNPL

About AVT Natural Products Ltd.

https://www.avtnatural.com/

AVT Natural Products Ltd. specializes in the production of plant-based extracts and natural ingredients for global markets. The company focuses on the solvent extraction and refining of botanical raw materials to produce high-quality oleoresins and essential oils. Its core product portfolio includes marigold oleoresins, which are processed into lutein for the nutraceutical industry, as well as spice oleoresins such as paprika, turmeric, and black pepper for food applications. Additionally, the company provides decaffeinated tea and coffee extracts. AVT Natural Products maintains a vertically integrated supply chain, encompassing seed development, cultivation support, and advanced processing technologies. This integration ensures traceability and adherence to international quality standards. The company serves diverse sectors, including food and beverage, animal nutrition, and health supplements, emphasizing sustainable sourcing and technical innovation.

Recent filings

Filing Released Lang Actions
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges referencing SEBI circulars related to fund raising by issuance of debt securities by large corporates. The company confirms it is not a Large Corporate as per the circulars. The document is short (1136 characters) and serves as a regulatory disclosure or compliance confirmation rather than a financial report or detailed update. It does not contain financial data, management discussion, or detailed capital structure changes. It is an initial disclosure related to fund raising regulations but does not announce actual fundraising or capital changes. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-04-27 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2026-04-09 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 85% confidence The document is a compliance certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, addressed to the stock exchanges and enclosing a registrar’s certificate for the quarter ended March 31, 2026. It contains no financial statements or substantive analysis; rather, it is an officer certification/regulatory submission. Under the instructions, such regulatory compliance certificates fall under "Regulatory Filings (RNS)" as a fallback for miscellaneous filings.
2026-04-09 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal notice addressed to stock exchanges regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations 2015. It specifies the period during which designated persons and their relatives cannot trade shares, linked to the upcoming declaration of audited financial results. The document is short (1225 characters) and serves as an announcement related to insider trading compliance rather than containing any financial data or report. It does not contain financial statements or detailed report content. Therefore, it is best classified as a Regulatory Filing (RNS), which covers compliance announcements and miscellaneous regulatory communications that do not fit other categories.
2026-03-26 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges informing about the closure of the trading window pursuant to SEBI regulations and the company's code of conduct. It specifies the trading window closure period related to the declaration of audited financial results for the quarter and year ending March 31, 2026. The document is short (1225 characters) and serves as a notification rather than containing any financial data or results. It does not contain any financial statements, management discussion, or detailed report content. Therefore, it is an announcement related to compliance and insider trading restrictions, not a financial report or earnings release. This fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2026-03-26 English
Updates
Interim / Quarterly Report Classification · 94% confidence The document comprises the board meeting outcome approving and publishing the unaudited standalone financial results for the third quarter and nine months ended 31 Dec 2025, includes the detailed financial statements and the independent auditor’s limited review report. This is a substantive interim/quarterly financial report rather than a brief earnings highlight or a simple publication notice. It therefore is classified as an Interim / Quarterly Report (IR). 9M 2026
2026-02-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.